Nu-Med Plus (NUMD) Enterprise Value Growth (5y) (2016 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67.72% |
| Sep 30, 2025 | 42.69% |
| Jun 30, 2025 | 32.38% |
| Mar 31, 2025 | 33.56% |
| Dec 31, 2024 | 19.64% |
| Sep 30, 2024 | 37.34% |
| Jun 30, 2024 | 23.76% |
| Mar 31, 2024 | 22.86% |
| Dec 31, 2023 | 47.31% |
| Sep 30, 2023 | 41.95% |
| Jun 30, 2023 | 36.42% |
| Mar 31, 2023 | 28.07% |
| Dec 31, 2022 | 26.92% |
| Sep 30, 2022 | 72.64% |
| Mar 31, 2022 | 61.89% |
| Dec 31, 2021 | 1.28% |
| Sep 30, 2021 | -87.25% |
| Jun 30, 2021 | -14.00% |
| Mar 31, 2021 | -9.71% |
| Dec 31, 2020 | -43.57% |